Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Actinic Keratosis Market Size From 2025 to 2034?
The market size for actinic keratosis has seen robust growth lately. It’s expected to expand from $7.95 billion in 2024 to $8.42 billion in 2025, generating a compound annual growth rate (CAGR) of 5.8%. This historic growth can be linked to factors such as an increase in UV radiation exposure, a growing elderly population, heightened awareness about skin cancer, a rising number of actinic keratosis cases, growth in healthcare infrastructure, increased disposable incomes, governmental support and prevention-focused skincare initiatives.
In the coming years, the actinic keratosis market is poised for robust growth, and it’s anticipated to reach$10.5 billion in 2029 with a compound annual growth rate (CAGR) of 5.7%. The growth factors during the predicted period include the development of ground-breaking treatments, progress in AI-empowered diagnostic tools, a surge in the acceptance of comprehensive therapies, increased interest in non-invasive methods, an expanding use of tele dermatology, a larger use of photodynamic therapy, enhanced cosmetic outcome awareness, the establishment of targeted biologic treatments, a rising investment in healthcare in emergent markets and a shift towards early detection and prevention. Noteworthy trends in the forecast period include diagnostic tools accelerated by AI, lesion analysis through machine learning, sophisticated photodynamic therapy systems, wearable UV monitoring gadgets, nanotechnology-oriented drug delivery, 3D imaging for individualized treatments, transportable home-based phototherapy tools, early detection biosensors, automated lesion categorization software, and hydrogel-infused therapeutic systems.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp
What External and Internal Drivers Are Contributing to the Growth of theActinic Keratosis Market?
The actinic keratosis market is set to thrive due to an uptick in severe sunburn incidences. Severe sunburns, a kind of acute skin burn brought about by overexposure to ultraviolet (UV) radiation results in symptoms like redness, swelling, pain, and potentially blisters. These sunburns are typically caused by prolonged UV exposure, inadequate sun protection, increased outdoor activities at peak UV hours and heightened temperatures attributed to climate change. Actinic keratosis arises from sunburns damaging skin cells’ DNA via UV radiation, leading to mutations that interrupt the normal functioning of cells. This eventually results in the formation of pre-cancerous lesions, especially with extended or repeated sun exposure. Case in point, Melanoma Focus, a UK charity, stated in May 2024 that in the span of 2022-23, 201 hospital admissions were due to sunburn, involving 89 children and 25 babies under one year old. The charity further discovered that 66% of UK adults aged 16-65 recollected being sunburnt as kids, with 65% of them having experienced severe blisters due to sunburn at least once. This figure increased to 77% for individuals with light, pale, or white skin. Hence, the escalation in severe sunburn cases is bolstering the actinic keratosis market’s growth.
What Segment Types Define the Actinic Keratosis Market Structure?
The actinic keratosismarket covered in this report is segmented –
1) By Treatment Type: Topical Treatment; Surgical Procedure; Photodynamic Therapy; Other Treatment Types
2) By Distribution Channels: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers
3) By End-User: Hospitals; Dermatology Clinics; Spas And Rejuvenation Centers; Homecare Settings; Other End-Users
Subsegments:
1) By Topical Treatment: 5-Fluorouracil (5-FU); Imiquimod; Diclofenac; Ingenol Mebutate; Retinoids
2) By Surgical Procedure: Cryotherapy; Curettage And Electrodessication; Excision
3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy; Methyl Aminolevulinate (MAL) Plus Light Therapy
4) By Other Treatment Types: Laser Therapy; Chemical Peels; Combination Therapies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Actinic Keratosis Market?
North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Actinic Keratosis Market?
Major players in the actinic keratosis market are concentrating their efforts on innovating topical ointments. The goal is to successfully target and eradicate precancerous lesions, decrease the likelihood of reoccurrence, and increase patient satisfaction by reducing the length of treatment and improving safety profiles. These topical ointments are medicated gels or creams that are applied to the impacted skin, consisting of active components like tirbanibulin that target abnormal keratinocytes and treat precancerous lesions. For example, in June 2024, Almirall SA, a biopharmaceutical company based in Spain, received approval from the US Food and Drug Administration (FDA) for supplemental new drug application (sNDA) to increase its drug, Klisyri, usage area to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment, a microtubule inhibitor, is intended to hinder the growth of abnormal keratinocytes, hence effectively reducing the quantity and size of precancerous lesions in treating actinic keratosis (AK) on the face or scalp.
View the full report here:
https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report
What Is the Definition of the Actinic Keratosis Market?
Actinic keratosis (AK), also known as solar keratosis, is a common precancerous skin condition that occurs due to prolonged exposure to ultraviolet (UV) radiation from the sun or artificial sources leading to rough, scaly or crusty patches on sun-exposed areas of the skin such as the face, scalp, hands and arms. It is considered an early stage of squamous cell carcinoma (SCC) and requires treatment to prevent progression. Regular skin checks and protection from sun exposure are essential for managing and preventing the development of actinic keratosis.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21077
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model